Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06075589

Psychoeducation for Uveal Melanoma

Promoting Adjustment in Uveal Melanoma Survivorship: A Randomized Trial Targeting Illness Perceptions

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Jonsson Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.

Detailed description

PRIMARY OBJECTIVE: I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in modifying illness perceptions of disease control, chronicity, and coherence (i.e., to become less threatening) over the course of the follow-up period. SECONDARY OBJECTIVE: I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in reducing the degree of participant's depressive and anxiety symptoms over the course of the follow-up period. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study. ARM II: Patients receive enhanced treatment as usual and receive a mental health resource information sheet on study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEducation for InterventionParticipants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study.
BEHAVIORALBest PracticePatients receive enhanced treatment as usual and receive a mental health resource information sheet on study.

Timeline

Start date
2023-11-07
Primary completion
2024-08-14
Completion
2027-12-01
First posted
2023-10-10
Last updated
2026-03-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06075589. Inclusion in this directory is not an endorsement.